Home > Products > CD19 & CD22
> Recombinant Anti-CD19 x Anti-CD22 Bispecific Antibody (Fab-IgG)
Recombinant Anti-CD19 x Anti-CD22 Bispecific Antibody (Fab-IgG) (CAT#: FABIG-039)
Recombinant Anti-CD19 x Anti-CD22 Bispecific Antibody (Fab-IgG) is designed to be expressed as three chains, assembling in vivo and resulting in the construct of Fab-IgG (Tandem Fab-Fc). Fab-IgG has standard Fab and Fc domains, with no mutations, which may permit it has similar affinity binding and PK profile comparable to the parental antibodies. This BsAb is designed for the research of B cell lymphoma; Leukemia therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD19 x Anti-CD22 Bispecific Antibody (Fab-IgG) (FABIG-039). Click the button below to contact us or submit your feedback about this product.